Are lower MRPs on cancer drugs translating into affordable care?
The Hindu — Health · 5 Nov 2026 · 1 min read
In a move to make cancer treatment more affordable, the National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, reducing the price of nearly 900 cancer medicine brands by up to 70%-93%.
However, for comprehensive cancer care in India, price regulation might not be enough.
Are lower MRPs on cancer drugs translating into affordable care?
Indu Bhushan and K.
M.
Gopakumar discuss the question in a conversation moderated by Bindu Shajan Perappadan.
Indu Bhushan is bureaucrat, economist and the first CEO of Ayushman Bharat; K.
M.
Gopakumar is legal adviser, senior researcher and public health expert
Related articles
India · The Hindu — Health · 1 day agoWhat do dark circles under a child’s eyes indicate?
Dark circles under a child’s eyes may not always be due to lack of sleep. Genetics, allergies and nasal congestion can also play a…
Read full article
India · The Hindu — Health · 1 day agoBreast cancer begins long before the lump: why diet and lifestyle matter
While genetic predisposition is one factor, a majority of breast cancers develop in women with no family history: metabolic health and physical inactivity play…
Read full article
India · The Hindu — Health · 1 day ago